Business Description
Veru Inc
NAICS : 541713
SIC : 2834
ISIN : US92536C1036
Description
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.8 | |||||
| Equity-to-Asset | 0.54 | |||||
| Debt-to-Equity | 0.43 | |||||
| Debt-to-EBITDA | -0.38 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -5.96 | |||||
| Beneish M-Score | -3.71 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -44.5 | |||||
| 3-Year EPS without NRI Growth Rate | -95.7 | |||||
| 3-Year FCF Growth Rate | 5.2 | |||||
| 3-Year Book Growth Rate | -51.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate | -8.61 | |||||
| Future 3-5Y Total Revenue Growth Rate | -13.07 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 51.66 | |||||
| 9-Day RSI | 47.31 | |||||
| 14-Day RSI | 47.07 | |||||
| 6-1 Month Momentum % | -5.24 | |||||
| 12-1 Month Momentum % | 7.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.97 | |||||
| Quick Ratio | 2.62 | |||||
| Cash Ratio | 2.1 | |||||
| Days Inventory | 181.94 | |||||
| Days Sales Outstanding | 66.04 | |||||
| Days Payable | 211.5 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -22.3 | |||||
| Shareholder Yield % | -33.74 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 34.66 | |||||
| Operating Margin % | -225.85 | |||||
| Net Margin % | -223.85 | |||||
| FCF Margin % | -128.88 | |||||
| ROE % | -101.39 | |||||
| ROA % | -57.72 | |||||
| ROIC % | -123.89 | |||||
| ROC (Joel Greenblatt) % | -581.79 | |||||
| ROCE % | -69.88 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 5.59 | |||||
| PB Ratio | 3.06 | |||||
| Price-to-Tangible-Book | 4.02 | |||||
| EV-to-EBIT | -2.41 | |||||
| EV-to-EBITDA | -2.43 | |||||
| EV-to-Revenue | 5.2 | |||||
| EV-to-Forward-Revenue | 6.28 | |||||
| EV-to-FCF | -4.05 | |||||
| Price-to-Median-PS-Value | 1.19 | |||||
| Price-to-Net-Current-Asset-Value | 12.87 | |||||
| Earnings Yield (Greenblatt) % | -41.49 | |||||
| FCF Yield % | -21.92 | |||||
| Forward Rate of Return (Yacktman) % | 2.17 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Veru Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 15.438 | ||
| EPS (TTM) (€) | -0.256 | ||
| Beta | 0.03 | ||
| Volatility % | 98.16 | ||
| 14-Day RSI | 47.07 | ||
| 14-Day ATR (€) | 0.020308 | ||
| 20-Day SMA (€) | 0.664025 | ||
| 12-1 Month Momentum % | 7.36 | ||
| 52-Week Range (€) | 0.3401 - 1.751 | ||
| Shares Outstanding (Mil) | 146.38 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Veru Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Veru Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Veru Inc Frequently Asked Questions
What is Veru Inc(FRA:FMW)'s stock price today?
The current price of FRA:FMW is €0.64. The 52 week high of FRA:FMW is €1.75 and 52 week low is €0.34.
When is next earnings date of Veru Inc(FRA:FMW)?
The next earnings date of Veru Inc(FRA:FMW) is 2025-02-07 Est..
Does Veru Inc(FRA:FMW) pay dividends? If so, how much?
Veru Inc(FRA:FMW) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers